ABOUT US
Transforming Precision Medicine with Multimodal AI
BioAI is an AI-powered biomarker and digital pathology company supporting pharma, research and laboratory partners through biomarker-focused services, AI model development, external validation and Research Use Only product development.
Our Mission
At BioAI, our mission is to develop AI-powered precision biomarkers and discover novel drug targets to accelerate clinical R&D and advance precision oncology.
Our Purpose
Our purpose is to develop AI solutions for precision oncology research that can help advance patient care in the future.
Our Values

Innovation
We are dedicated to innovation, continuously advancing AI methods for biomarker research and precision oncology.

Patient Impact
Our work aims to contribute to more personalized cancer care in the future, starting with better biomarker research today.

Integrity
Upholding the highest ethical standards is essential in our field where research and development directly impact patient care and also often involve sensitive information. From partner and patient confidentiality to ethical AI, we maintain integrity in all aspects of operations.

Collaboration
BioAI believes in the power of interdisciplinary collaboration and teamwork bringing together experts from multiple fields and fostering relationships with healthcare providers, research institutions and biopharmaceutical partners.
PEOPLE
Meet the Team
Meet our leadership team and advisors. Our multidisciplinary team brings expertise across machine learning, pathology, medicine and biology.
Leadership Team
Board of Advisors
Hon. Prof. Tom Chittenden, PhD, DPhil, DSPE
SAB Chairman; Chief Scientific Officer, Profound Therapeutics; Honorary Professor of AI in Biomedicine, Queen Mary University of London
Paolo Ascierto, MD
Director of the Department of Melanoma Cancer Immunotherapy, Institute of National Tumor IRCCS Foundation
Carlo Bifulco, MD
Chief Medical Officer of Providence Genomics, Medical Director, Translational Pathology, Earle A. Chiles Research Institute
Greg Slabaugh, PhD
Professor, and Director of the Digital Environment Research Institute (DERI), Queen Mary University of London